These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 24830937)

  • 1. Oral magnesium supplementation improves the metabolic profile of metabolically obese, normal-weight individuals: a randomized double-blind placebo-controlled trial.
    Rodríguez-Moran M; Guerrero-Romero F
    Arch Med Res; 2014 Jul; 45(5):388-93. PubMed ID: 24830937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study.
    Toprak O; Kurt H; Sarı Y; Şarkış C; Us H; Kırık A
    Kidney Blood Press Res; 2017; 42(1):33-42. PubMed ID: 28297698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral Magnesium Supplementation and Metabolic Syndrome: A Randomized Double-Blind Placebo-Controlled Clinical Trial.
    Rodríguez-Morán M; Simental-Mendía LE; Gamboa-Gómez CI; Guerrero-Romero F
    Adv Chronic Kidney Dis; 2018 May; 25(3):261-266. PubMed ID: 29793665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral magnesium supplementation improves glycaemic status in subjects with prediabetes and hypomagnesaemia: A double-blind placebo-controlled randomized trial.
    Guerrero-Romero F; Simental-Mendía LE; Hernández-Ronquillo G; Rodriguez-Morán M
    Diabetes Metab; 2015 Jun; 41(3):202-7. PubMed ID: 25937055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum magnesium in the metabolically-obese normal-weight and healthy-obese subjects.
    Guerrero-Romero F; Rodriguez-Moran M
    Eur J Intern Med; 2013 Oct; 24(7):639-43. PubMed ID: 23523313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial.
    Rodríguez-Morán M; Guerrero-Romero F
    Diabetes Care; 2003 Apr; 26(4):1147-52. PubMed ID: 12663588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial.
    Guerrero-Romero F; Tamez-Perez HE; González-González G; Salinas-Martínez AM; Montes-Villarreal J; Treviño-Ortiz JH; Rodríguez-Morán M
    Diabetes Metab; 2004 Jun; 30(3):253-8. PubMed ID: 15223977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral magnesium supplementation decreases C-reactive protein levels in subjects with prediabetes and hypomagnesemia: a clinical randomized double-blind placebo-controlled trial.
    Simental-Mendía LE; Rodríguez-Morán M; Guerrero-Romero F
    Arch Med Res; 2014 May; 45(4):325-30. PubMed ID: 24814039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects - a double-blind, placebo-controlled, randomized trial.
    Mooren FC; Krüger K; Völker K; Golf SW; Wadepuhl M; Kraus A
    Diabetes Obes Metab; 2011 Mar; 13(3):281-4. PubMed ID: 21205110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of oral magnesium supplementation in the treatment of depression in the elderly with type 2 diabetes: a randomized, equivalent trial.
    Barragán-Rodríguez L; Rodríguez-Morán M; Guerrero-Romero F
    Magnes Res; 2008 Dec; 21(4):218-23. PubMed ID: 19271419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: a randomized, double-blind, placebo-controlled clinical trial.
    Guerrero-Romero F; Rodríguez-Morán M
    J Hum Hypertens; 2009 Apr; 23(4):245-51. PubMed ID: 19020533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of magnesium supplements on early post-transplantation glucose metabolism: a randomized controlled trial.
    Van Laecke S; Nagler EV; Taes Y; Van Biesen W; Peeters P; Vanholder R
    Transpl Int; 2014 Sep; 27(9):895-902. PubMed ID: 24909487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety profile of fenofibrate-coated microgranules 130 mg, with and without food, in patients with hypertriglyceridemia and the metabolic syndrome: an 8-week, randomized, double-blind, placebo-controlled study.
    Davidson MH; Bays H; Rhyne J; Stein E; Rotenberg K; Doyle R
    Clin Ther; 2005 Jun; 27(6):715-27. PubMed ID: 16117978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc supplementation and the effects on metabolic status in gestational diabetes: A randomized, double-blind, placebo-controlled trial.
    Karamali M; Heidarzadeh Z; Seifati SM; Samimi M; Tabassi Z; Hajijafari M; Asemi Z; Esmaillzadeh A
    J Diabetes Complications; 2015; 29(8):1314-9. PubMed ID: 26233572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of sibutramine on body weight and serum lipids: a double-blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemia.
    Dujovne CA; Zavoral JH; Rowe E; Mendel CM;
    Am Heart J; 2001 Sep; 142(3):489-97. PubMed ID: 11526363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of adjunctive metformin on metabolic traits in nondiabetic clozapine-treated patients with schizophrenia and the effect of metformin discontinuation on body weight: a 24-week, randomized, double-blind, placebo-controlled study.
    Chen CH; Huang MC; Kao CF; Lin SK; Kuo PH; Chiu CC; Lu ML
    J Clin Psychiatry; 2013 May; 74(5):e424-30. PubMed ID: 23759461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects.
    Wilding J; Van Gaal L; Rissanen A; Vercruysse F; Fitchet M;
    Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1399-410. PubMed ID: 15486569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnesium Supplementation and the Effects on Wound Healing and Metabolic Status in Patients with Diabetic Foot Ulcer: a Randomized, Double-Blind, Placebo-Controlled Trial.
    Razzaghi R; Pidar F; Momen-Heravi M; Bahmani F; Akbari H; Asemi Z
    Biol Trace Elem Res; 2018 Feb; 181(2):207-215. PubMed ID: 28540570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta-analysis of randomized double-blind controlled trials.
    Song Y; He K; Levitan EB; Manson JE; Liu S
    Diabet Med; 2006 Oct; 23(10):1050-6. PubMed ID: 16978367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study investigating the effect of Caralluma fimbriata extract on the risk factors of metabolic syndrome in overweight and obese subjects: a randomised controlled clinical trial.
    Astell KJ; Mathai ML; McAinch AJ; Stathis CG; Su XQ
    Complement Ther Med; 2013 Jun; 21(3):180-9. PubMed ID: 23642949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.